These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Nimmrich V, Ebert U. Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730 [Abstract] [Full Text] [Related]
5. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease. Li S, Jin M, Liu L, Dang Y, Ostaszewski BL, Selkoe DJ. Acta Neuropathol Commun; 2018 Nov 08; 6(1):121. PubMed ID: 30409172 [Abstract] [Full Text] [Related]
7. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T. Brain Nerve; 2010 Jul 08; 62(7):691-9. PubMed ID: 20675873 [Abstract] [Full Text] [Related]
8. Synaptic Plasticity, Dementia and Alzheimer Disease. Skaper SD, Facci L, Zusso M, Giusti P. CNS Neurol Disord Drug Targets; 2017 Jul 08; 16(3):220-233. PubMed ID: 28088900 [Abstract] [Full Text] [Related]
11. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice. Müller MK, Jacobi E, Sakimura K, Malinow R, von Engelhardt J. Acta Neuropathol Commun; 2018 Oct 23; 6(1):110. PubMed ID: 30352630 [Abstract] [Full Text] [Related]
12. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease. Pinheiro L, Faustino C. Curr Alzheimer Res; 2019 Oct 23; 16(5):418-452. PubMed ID: 30907320 [Abstract] [Full Text] [Related]
13. Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. Chung E, Ji Y, Sun Y, Kascsak RJ, Kascsak RB, Mehta PD, Strittmatter SM, Wisniewski T. BMC Neurosci; 2010 Oct 14; 11():130. PubMed ID: 20946660 [Abstract] [Full Text] [Related]
16. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease. Shi XD, Sun K, Hu R, Liu XY, Hu QM, Sun XY, Yao B, Sun N, Hao JR, Wei P, Han Y, Gao C. J Neurosci; 2016 Nov 23; 36(47):11959-11973. PubMed ID: 27881781 [Abstract] [Full Text] [Related]
18. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease. Zeng Y, Zhang J, Zhu Y, Zhang J, Shen H, Lu J, Pan X, Lin N, Dai X, Zhou M, Chen X. J Neurochem; 2015 Apr 23; 133(1):38-52. PubMed ID: 25661995 [Abstract] [Full Text] [Related]
19. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease. Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL. Eur J Neurosci; 2016 Dec 23; 44(12):3056-3066. PubMed ID: 27748574 [Abstract] [Full Text] [Related]
20. Non-Fibrillar Oligomeric Amyloid-β within Synapses. Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL. J Alzheimers Dis; 2016 May 30; 53(3):787-800. PubMed ID: 27258414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]